Sixty percent of patients with baseline UUI experienced complete resolution at one year post-surgery, independent of sling type. De novo UUI was observed in 11% of patients, with colpocleisis ...

The IRA caps Medicare Part D out-of-pocket costs at $2000 annually, significantly reducing financial toxicity for cancer patients. Allowing Medicare to negotiate drug prices may increase access to ...

"This is another tool in our armamentarium to treat muscle-invasive bladder cancer and represents an advance compared to where we've been over the past few decades," says Matthew D. Galsky, MD. The ...

"We demonstrate that patients with metastatic disease stayed on therapy longer—a median of 9 months vs 7 months for the non-metastatic patients," says Rana R. McKay, MD, FASCO. Overall, data from the ...

UroLift patients demonstrated superior recovery outcomes, including higher satisfaction and improved sexual function, compared to Rezūm patients. The study showed significant differences in ...

home / sap-partner / icahn-school-of-medicine-at-mount-sinai ...

ProACT is recommended for non-radiated patients with stress urinary incontinence, offering adjustability for mild to severe cases. The procedure combines cystoscopy and fluoroscopy, with postoperative ...

"We see the overall survival, whether it is [in] all-comers, in HRR gene mutation-positive patients, or in HRR gene [mutation]-negative patients or [those] who did not have mutations, the overall ...

“If it is as efficacious as it looks, we will have more patients who are getting effective standard of care treatment, not needing to go on to further treatment, not having recurrences, [having ...

Experts discuss how they communicate various treatment options for non–muscle-invasive bladder cancer (NMIBC) with patients and health care professionals.

"We must lobby to maintain our current funding levels and push for increased support to continue driving progress in cancer care," says Michael S. Cookson, MD, MMHC, FACS. “Healthy citizens are the ...

Jack R. Andrews, MD; Eugene B. Cone MD; and Edwin Posadas, MD, FACP, discuss how early intervention with individualized treatment approaches based on disease volume, patient characteristics, and ...